✨ Health-related appointments and medicine consents




4 AUGUST 2011 NEW ZEALAND GAZETTE, No. 118 3301

as pharmacist members of the Health Practitioners Disciplinary Tribunal.
These appointments are for five-year terms of office commencing on the date of this notification.
Dated at Ohope Beach this 26th day of July 2011.

HON TONY RYALL, Minister of Health.

go5337

Judith McAra-Couper

as a health practitioner member of the Midwifery Council for a three-year term of office commencing on the date of this notification; and appoint

Bronwen Golder

as a lay member of the Midwifery Council for a three-year term of office commencing on the date of this notification.

Dated at Whakatane this 28th day of July 2011.

Reappointment/appointment to the Midwifery Council

Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, I reappoint

HON TONY RYALL, Minister of Health.

go5340

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Aspen Adrenaline
Active Ingredient: Adrenaline 1mg/10mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Biologici Italia Laboratoires Srl, Novate Milanese, Milan, Italy
Biologici Italia Laboratoires Srl, Masate, Milan, Italy

Product: DBL Docetaxel, Concentrated Injection
Active Ingredient: Docetaxel 10mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Hospira NZ Limited
Manufacturers: Hospira Australia Pty Limited, Mulgrave, Australia
Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India

Product: Telfast Children’s Elixir
Active Ingredient: Fexofenadine hydrochloride 6mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: sanofi-aventis us llc, Missouri, United States of America

Dated this 28th day of July 2011.

MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5233

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Actilyse
Active Ingredient: Alteplase 10mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Product: Actilyse
Active Ingredient: Alteplase 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 118





✨ LLM interpretation of page content

πŸ₯ Reappointment/appointments to the Health Practitioners Disciplinary Tribunal (continued from previous page)

πŸ₯ Health & Social Welfare
26 July 2011
Health Practitioners, Disciplinary Tribunal, Appointments
  • HON TONY RYALL, Minister of Health

πŸ₯ Reappointment/appointment to the Midwifery Council

πŸ₯ Health & Social Welfare
28 July 2011
Midwifery Council, Appointments
  • Judith McAra-Couper, Reappointed as health practitioner member
  • Bronwen Golder, Appointed as lay member

  • HON TONY RYALL, Minister of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
28 July 2011
Medicines, Distribution Consent
  • MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
28 July 2011
Medicines, Distribution Consent
  • MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health